title: How many "me-too" drugs is too many?
authors.affiliation: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, Boston, MA 02120, USA.
authors.forename: Joshua J
authors.initials: JJ
authors.lastname: Gagne
authors.forename: Niteesh K
authors.initials: NK
authors.lastname: Choudhry
mesh_terms: D017277:Drug Approval; D055808:Drug Discovery; D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011804:Quinolines; C108475:pitavastatin